Recent technological advancements have created significant demand in the hair loss treatment market. For instance, in October 2020, LG Electronics Inc. announced that it will launch a hair loss treatment device in South Korea. LG Pra.L MediHair was recently approved by Seoul’s drug safety ministry as a laser apparatus for medical use and was also cleared by the USFDA as a Class II device for home use. However, factors such as high cost of medication and the presence of an alternative treatment options are going to restrain the hair loss treatment market growth.
Major Company Profiles Covered in This Report: Viviscal, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, Ranbaxy Laboratories Ltd, HCell Inc., Follica, Inc., Aurobindo Pharma, and Zydus Pharmaceuticals, Inc. (Zydus Cadila), among others.
FREE | Request Sample is Available @
*The Sample only consist of Table of Content (ToC).
Research Framework of the actual report.
Research Methodology adopted for it.
Hair loss can be caused by numerous disorders. Alopecia areata or hair loss begins after the onset of puberty. Alopecia is a common autoimmune disorder that often results in unpredictable hair loss on the scalp, face, and other areas of the body. Thus, with the increasing incidence of alopecia areata, the demand for hair loss treatment is also increasing, driving the hair loss treatment growth. For instance, in March 2020, Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of alopecia areata.
In April 2020, Phyto launched new anti-hair loss products, such as Phytonovathrix Global Anti-Hair Loss Treatment, Pyhtonovathrix Fortifying Energizing Shampoo, and Phytonovathrix Hair Energising Mass Lotion, which leverage on the ‘wnt protein’, to trigger the growth cycle.
Hair loss is more common in men. It is most prominent in the vertex and frontotemporal regions, while in females the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair. In females, thyroid problems, menopause, childbirth, and pregnancy are some of the conditions that may cause temporary or permanent or hair loss. The major factors driving the hair loss treatment market are adoption of a hectic schedule and changing lifestyle patterns, which increases stress levels and results in frequent hair loss, increased emphasis on appearances and growing disposable income.
Download Free PDF Brochure @
Frequently Asked Questions
What are the key factors driving Hair Loss Treatment Market expansion?
What will be the value of Hair Loss Treatment Market during 2020- 2027?
Which region will make notable contributions towards global Hair Loss Treatment Market revenue?
What are the key players leveraging Hair Loss Treatment Market growth?
Also, Research Report Examines:
Competitive companies and manufacturers in global market
By Product Type, Applications & Growth Factors
Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.